<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02360085</url>
  </required_header>
  <id_info>
    <org_study_id>UHN REB # 14-8164</org_study_id>
    <nct_id>NCT02360085</nct_id>
  </id_info>
  <brief_title>Does Heart Rate Variablity (HRV) Predict Hypotension in Patients Undergoing Cervical Myelopathy Surgery ?</brief_title>
  <official_title>Does Heart Rate Variablity (HRV) Predict Hypotension on Induction in Patients Undergoing Surgery for Cervical Myelopathy ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lashmi Venkatraghavan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cervical myelopathy is commonly associated with degenerative spinal disease. Dysfunction of&#xD;
      the autonomic nervous system is also evident in many cases of cervical myelopathy. Autonomic&#xD;
      dysfunction may result in haemodynamic instability and hypotension under anaesthesia. It is&#xD;
      important to maintain adequate mean arterial pressure in order to perfuse the spinal cord and&#xD;
      prevent cord ischemia. Heart rate variability, the physiological variations of the&#xD;
      differences between heart beats, has been used to diagnose autonomic dysfunction. In patients&#xD;
      with cervical myelopathy it may enable the anaesthetist to predict hypotension thereby&#xD;
      allowing for early treatment and prevention of spinal cord ischemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Protocol&#xD;
&#xD;
        1. Standard perioperative management Routine standard preparation of the patients will be&#xD;
           carried out as per the investigators institutional standard for all patients undergoing&#xD;
           cervical spine surgery. All routine physiological monitoring (ECG, invasive arterial&#xD;
           blood pressure, SPO2, end tidal CO2, temperature and depth of anaesthesia monitoring)&#xD;
           will be performed. The induction of anesthesia will be performed with propofol (2-5&#xD;
           mg/kg), fentanyl (3mcg/Kg) and rocuronium (0.6 mg/kg) for intubation of the patient's&#xD;
           trachea once peripheral nerve stimulation shows no muscle twitches.&#xD;
&#xD;
        2. Study protocol Before general anesthesia, following a 10 minute stabilization period&#xD;
           with the patient lying supine and breathing at a rate of 12 - 15 breaths per minute, a 5&#xD;
           minute ECG recording will be obtained. ECG data will be downloaded onto a study laptop&#xD;
           for later analysis using LabChart Software to determine HRV values. Hemodynamic data and&#xD;
           depth of anaesthesia will be collected from the preinduction period until skin incision&#xD;
           at 1 minute intervals. The study will be complete after skin incision.&#xD;
&#xD;
      Data Collection and Management Data Collection The following data will be collected: patient&#xD;
      demographics, surgical data including position technique, number of levels, duration,&#xD;
      anaesthetic data including agents used, hemodynamic measurements from preinduction to&#xD;
      surgical incision, Japanese Orthopaedic Association Score. The incidence of hypotension and&#xD;
      the number of interventions required to keep mean arterial blood pressure above 70 mmHg will&#xD;
      be recorded.&#xD;
&#xD;
      Significance of the study Identifying patients at risk for hypotension can be useful to&#xD;
      prevent hypotension and to prepare to treat hypotension sooner so that the risk of spinal&#xD;
      cord ischemia can be minimized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2015</start_date>
  <completion_date type="Actual">April 2020</completion_date>
  <primary_completion_date type="Actual">October 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate Variability (HRV)</measure>
    <time_frame>1 day</time_frame>
    <description>Difference between total power (ms2) of patients in the hypotension group compared to stable group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HRV Indices</measure>
    <time_frame>1 day</time_frame>
    <description>Differences in HRV indices between hypotension group and no hypotension group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Arterial Pressure</measure>
    <time_frame>one day</time_frame>
    <description>Preoperative Analysis Mean Arterial Pressure between hypotension group and no hypotension group</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HRV Indices Analysis</measure>
    <time_frame>One day</time_frame>
    <description>Low frequency (LF)/High frequency Ratio</description>
  </primary_outcome>
  <enrollment type="Actual">65</enrollment>
  <condition>Heart Rate Variability</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cervical myelopathy presenting for cervical spine surgery at Toronto Western&#xD;
        Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults patients, aged 18 - 70 years with the history of cervical myelopathy,&#xD;
             presenting for anterior or posterior cervical decompression and fusion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with arrhythmias or absence of sinus rhythm&#xD;
&#xD;
          2. Diabetic patients&#xD;
&#xD;
          3. Degenerative neurological disease e.g. Parkinson's disease&#xD;
&#xD;
          4. Complete SCI&#xD;
&#xD;
          5. Inherited autonomic dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lashmi Venkatraghavan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesia, Toronto Western Hospital. University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 2, 2015</study_first_submitted>
  <study_first_submitted_qc>February 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2015</study_first_posted>
  <results_first_submitted>May 11, 2020</results_first_submitted>
  <results_first_submitted_qc>December 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 16, 2020</results_first_posted>
  <last_update_submitted>December 14, 2020</last_update_submitted>
  <last_update_submitted_qc>December 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Lashmi Venkatraghavan</investigator_full_name>
    <investigator_title>Director, Neuroanesthesia, Toronto Western Hospital</investigator_title>
  </responsible_party>
  <keyword>Cervical Myelopathy</keyword>
  <keyword>Hypotension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 2, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/85/NCT02360085/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cervical Myelopathy Undergoing Spine Surgery</title>
          <description>This is a prospective, single-center, observational study in adult (aged 18-70 years) patients undergoing elective anterior or posterior cervical decompression and fusion for cervical myelopathy in our institution during the period from Sept 2017 to June 2018.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>In total 65 patients were recruited for the study and 16 patients were excluded. 49 patients were included for final analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Cervical Myelopathy Undergoing Spine Surgery</title>
          <description>This is a prospective, single-center, observational study in adult (aged 18-70 years) patients undergoing elective anterior or posterior cervical decompression and fusion for cervical myelopathy in our institution during the period from Sept 2017 to June 2018.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>49 patients were included for final analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cervical myelopathy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>mild</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>moderate to severe</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Heart Rate Variability (HRV)</title>
        <description>Difference between total power (ms2) of patients in the hypotension group compared to stable group</description>
        <time_frame>1 day</time_frame>
        <population>All data are presented as Median [Interquartile range]</population>
        <group_list>
          <group group_id="O1">
            <title>Hypotension Group</title>
            <description>HRV analysis in hypotension group</description>
          </group>
          <group group_id="O2">
            <title>No Hypotension Group</title>
            <description>HRV analysis in stable group</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate Variability (HRV)</title>
          <description>Difference between total power (ms2) of patients in the hypotension group compared to stable group</description>
          <population>All data are presented as Median [Interquartile range]</population>
          <units>ms2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1439" lower_limit="637.9" upper_limit="3130.5"/>
                    <measurement group_id="O2" value="2191" lower_limit="1229.5" upper_limit="2613.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>HRV Indices</title>
        <description>Differences in HRV indices between hypotension group and no hypotension group</description>
        <time_frame>1 day</time_frame>
        <population>All data are presented as Median [Interquartile range]. VLF- very low frequency, LF-low frequency, HF- high frequency.</population>
        <group_list>
          <group group_id="O1">
            <title>Hypotension Group</title>
            <description>VLF, LF and HF analysis</description>
          </group>
          <group group_id="O2">
            <title>No Hypotension Group</title>
            <description>VLF, LF and HF analysis</description>
          </group>
        </group_list>
        <measure>
          <title>HRV Indices</title>
          <description>Differences in HRV indices between hypotension group and no hypotension group</description>
          <population>All data are presented as Median [Interquartile range]. VLF- very low frequency, LF-low frequency, HF- high frequency.</population>
          <units>ms2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VLF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="684.8" lower_limit="411.8" upper_limit="1399.5"/>
                    <measurement group_id="O2" value="705.8" lower_limit="566.8" upper_limit="1649.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="290.2" lower_limit="143.6" upper_limit="1208.0"/>
                    <measurement group_id="O2" value="406.5" lower_limit="236.3" upper_limit="934.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HF</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109.7" lower_limit="64.8" upper_limit="430.8"/>
                    <measurement group_id="O2" value="350.4" lower_limit="185.7" upper_limit="1634.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Arterial Pressure</title>
        <description>Preoperative Analysis Mean Arterial Pressure between hypotension group and no hypotension group</description>
        <time_frame>one day</time_frame>
        <population>All data are presented as Median [Interquartile range]</population>
        <group_list>
          <group group_id="O1">
            <title>Hypotension Group</title>
            <description>Mean Arterial Pressure analysis in hypotension group</description>
          </group>
          <group group_id="O2">
            <title>No Hypotension Group</title>
            <description>Mean Arterial Pressure analysis in no hypotension</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure</title>
          <description>Preoperative Analysis Mean Arterial Pressure between hypotension group and no hypotension group</description>
          <population>All data are presented as Median [Interquartile range]</population>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.0" lower_limit="89.8" upper_limit="102.3"/>
                    <measurement group_id="O2" value="104.3" lower_limit="93.2" upper_limit="111.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>HRV Indices Analysis</title>
        <description>Low frequency (LF)/High frequency Ratio</description>
        <time_frame>One day</time_frame>
        <population>Low Frequency to High Frequency ratio. All data are presented as Median [Interquartile range].</population>
        <group_list>
          <group group_id="O1">
            <title>Hypotension Group</title>
            <description>Low Frequency to High Frequency ratio</description>
          </group>
          <group group_id="O2">
            <title>No Hypotension Group</title>
            <description>Low Frequency to High Frequency ratio</description>
          </group>
        </group_list>
        <measure>
          <title>HRV Indices Analysis</title>
          <description>Low frequency (LF)/High frequency Ratio</description>
          <population>Low Frequency to High Frequency ratio. All data are presented as Median [Interquartile range].</population>
          <units>Ratio</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.33" lower_limit="1.93" upper_limit="4.95"/>
                    <measurement group_id="O2" value="1.22" lower_limit="0.22" upper_limit="1.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>No adverse event observed</desc>
      <group_list>
        <group group_id="E1">
          <title>All Patients</title>
          <description>Heart Rate Variability in Patients with Cervical Myelopathy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Emad Al Azazi</name_or_title>
      <organization>Toronto Western Hospital/UHN</organization>
      <phone>416-603-8500 ext 6237</phone>
      <email>emad.alazazi@uhnresearch.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

